Drug Profile
VXL 303
Alternative Names: VXL-303Latest Information Update: 02 Jun 2021
Price :
$50
*
At a glance
- Originator Vaxil BioTherapeutics
- Class COVID-19 vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - COVID 2019 infections
Highest Development Phases
- Suspended COVID 2019 infections